NCT04168970 (LIVE) is a clinical trial of PSGB in Out-Of-Hospital Cardiac Arrest, sponsored by Fondazione IRCCS Policlinico San Matteo di Pavia.

Who is sponsoring NCT04168970?

NCT04168970 is sponsored by Fondazione IRCCS Policlinico San Matteo di Pavia.

What drugs are being tested in NCT04168970?

Interventions in NCT04168970: PSGB.

What condition does NCT04168970 study?

NCT04168970 studies Out-Of-Hospital Cardiac Arrest, Ventricular Fibrillation Sustained.

Is NCT04168970 still recruiting?

NCT04168970 is currently status unknown. Last updated 8 March 2024.

Last reviewed 2024-03-08 · How we verify

NCT04168970: LIVE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Percutaneous Left Stellate Ganglion Block In Out-of-hospital Cardiac Arrest Due to Refractory VEntricular Arrhythmias (LIVE Study)

Status unknown Last updated 8 March 2024

What this trial tests

trial testing PSGB in Out-Of-Hospital Cardiac Arrest in 53 participants. Status unknown.

Timeline

15 July 2019

Primary endpoint
31 July 2025

31 July 2025

Quick facts

Lead sponsor	Fondazione IRCCS Policlinico San Matteo di Pavia
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	53
Start date	15 July 2019
Primary completion	31 July 2025
Estimated completion	31 July 2025
Sites	1 location across Italy

Drugs / interventions tested

PSGB

Conditions studied

Out-Of-Hospital Cardiac Arrest — all drugs for Out-Of-Hospital Cardiac Arrest →
Ventricular Fibrillation Sustained — all drugs for Ventricular Fibrillation Sustained →

Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia

Who can join

Adults 18 to 100, any sex, with Out-Of-Hospital Cardiac Arrest or Ventricular Fibrillation Sustained. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective uncontrolled study to verify the feasibility and practicability of percutaneous stellate ganglion block (PSGB) in patient suffering from a refractory out-of-hospital cardiac arrest (OHCA) due to a shockable rhythm and the eventual occurrence of complication related to it. The study will also assess whether the rate of return of spontaneous circulation (ROSC) until admission and transfer of care to the receiving hospital is higher in the patients treated with PSGB as compared to historical controls.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Continuous stellate ganglion block for ventricular arrhythmias: case series, systematic review, and differences from thoracic epidural anaesthesia.
Dusi V, Angelini F, Baldi E, Toscano A, et al · · 2024 · cited 17× · PMID 38531027 · DOI 10.1093/europace/euae074
Neuromodulatory Approaches for Atrial Fibrillation Ablation.
Rodríguez-Mañero M, Martínez-Sande JL, García-Seara J, González-Ferrero T, et al · · 2021 · cited 1× · PMID 35024055 · DOI 10.15420/ecr.2021.05

Verify or expand the search:

Other recruiting trials for Out-Of-Hospital Cardiac Arrest

Currently open trials in the same condition.

NCT06538155 — Technological and Patient-tailored Innovations for Maximizing Effectiveness of Cardiac Arrest Resuscitation · recruiting
NCT06530433 — Enhanced Community First Responder System Evaluation in Singapore · NA · recruiting
NCT06203847 — The Effect of Prehospital Combination of Epinephrine, Vasopressin, and Steroid in OHCA · NA · recruiting
NCT06306625 — REmote COnditioning in Out-of-Hospital Cardiac Arrest · NA · recruiting
NCT06071910 — Emergency Resuscitative Endovascular Balloon Occlusion of the Aorta in Out of Hospital Cardiac Arrest · NA · recruiting

Other Fondazione IRCCS Policlinico San Matteo di Pavia trials

Trials by the same sponsor.

NCT07534007 — Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zo · recruiting
NCT07494344 — Italian Retrospective/Prospective Observational Study on Prosthetic Surgery in Patients With Congenital Coagulation Dise · recruiting
NCT07356583 — Neonatal Enterovirus Infections in Italy: Virological Characterization, Genomic and Clinical-epidemiological Insights on · recruiting
NCT07435207 — Thrombotic RIsk FActors in AL-goneurodystrophy · enrolling by invitation
NCT07263802 — Effect of a Food Supplement on Glycemic Parameters in Patients With Impaired Glucose Metabolism · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04168970 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fondazione IRCCS Policlinico San Matteo di Pavia
Last refreshed: 8 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04168970.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing